Skip to main content
FinSpry Logo
FinSpry
OVID logo
OVID
(NASDAQ)
Ovid Therapeutics Inc.
$2.40-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ovid Therapeutics (OVID) Stock Price & Financial Analysis

Ovid Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.29 - $2.43
52-Week High$3.11
52-Week Low$0.48
Open$2.36
Volume4.73M
Average Volume (3M)3.09M
Market Cap175.49M
Shares Outstanding73.74M
Price to Sales (P/S)25.37
Price to Book (P/B)0.91
EV/EBITDA-1.88
Revenue (TTM)7.12M
Net Income (TTM)-24.17M
Free Cash Flow (TTM)-41.95M
EPS (TTM)$-0.32
Profit Margin-339.33%
Operating Margin-670.25%
Return on Equity (ROE)-12.19%
Debt to Equity0.01
50-Day MA$2.52
200-Day MA$2.00
52-Week Change411.16%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ovid Therapeutics

What is the current stock price for OVID?

As of the latest trading session, OVID stock trades at $2.40. The 52-week range is $0.48–$3.11, with a day range of $2.29–$2.43.

What is the P/E ratio for OVID?

The P/E ratio (Price-to-Earnings) for OVID is shown in the Key Statistics section. This valuation metric helps compare Ovid Therapeutics Inc. to industry peers.

Does OVID pay dividends?

Ovid Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OVID?

Based on 7 analysts, the consensus for OVID is Buy.

What is the market cap of OVID?

Ovid Therapeutics's market capitalization is $177.0M, classifying it as a micro-cap company. Ovid Therapeutics operates in the Healthcare sector within the Biotechnology industry.